Aquaporin (AQP)4 is considered a potential autoantigen in patients with NMO after an autoantibody, designated NMO-IgG, that binds to human (h) AQP4 was detected in the serum of the vast majority of patients with NMO [3, 4]. This evidence concerns the gene AQP4 and neuromyelitis optica.